CN Patent

CN119606966A — 治疗前列腺癌的方法

Assigned to Janssen Pharmaceutica NV · Expires 2025-03-14 · 1y expired

What this patent protects

本发明涉及治疗前列腺癌的方法。本发明公开了通过向对其有需要的受试者施用尼拉帕尼来治疗前列腺癌的方法。

USPTO Abstract

本发明涉及治疗前列腺癌的方法。本发明公开了通过向对其有需要的受试者施用尼拉帕尼来治疗前列腺癌的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN119606966A
Jurisdiction: CN
Classification: —
Expires: 2025-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.